First National Bank of Omaha Takes $604,000 Position in The Clorox Company $CLX

First National Bank of Omaha bought a new stake in The Clorox Company (NYSE:CLX) in the 3rd quarter, HoldingsChannel.com reports. The firm bought 4,900 shares of the company’s stock, valued at approximately $604,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Clorox by 4.0% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock valued at $1,970,000 after purchasing an additional 514 shares in the last quarter. Woodline Partners LP grew its stake in Clorox by 253.7% in the 1st quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after acquiring an additional 7,465 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Clorox in the 2nd quarter valued at $216,000. Chicago Partners Investment Group LLC raised its position in Clorox by 29.7% during the second quarter. Chicago Partners Investment Group LLC now owns 2,514 shares of the company’s stock worth $330,000 after acquiring an additional 575 shares during the period. Finally, Stephens Inc. AR lifted its holdings in Clorox by 32.4% during the second quarter. Stephens Inc. AR now owns 3,778 shares of the company’s stock valued at $454,000 after purchasing an additional 924 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Down 0.9%

Shares of NYSE CLX opened at $122.04 on Friday. The company has a market capitalization of $14.76 billion, a P/E ratio of 19.94, a P/E/G ratio of 0.61 and a beta of 0.59. The company has a debt-to-equity ratio of 71.03, a current ratio of 0.74 and a quick ratio of 0.48. The company has a 50 day simple moving average of $109.36 and a 200-day simple moving average of $113.68. The Clorox Company has a 1 year low of $96.66 and a 1 year high of $159.04.

Clorox (NYSE:CLX) last posted its earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.43 by ($0.04). The business had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a return on equity of 383.01% and a net margin of 11.17%.Clorox’s revenue was down .8% compared to the same quarter last year. During the same period last year, the business earned $1.55 EPS. On average, equities research analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

More Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Clorox published a consumer research report, “Home Care Redefined,” highlighting shifting demand toward wellness‑focused and convenience‑oriented home care — a narrative that supports Clorox’s premium, innovation and marketing strategies and could help sustain pricing/brand strength. Home Care Redefined
• Neutral Sentiment: Management presented prepared remarks at the Consumer Analyst Group of New York (CAGNY) conference; these presentations typically reiterate strategy and portfolio priorities but rarely change near‑term financials unless new guidance is provided. Investors will be watching for Q&A takeaways on cost savings, innovation cadence and margin recovery. CAGNY Prepared Remarks Transcript
• Neutral Sentiment: Wells Fargo reiterated a Hold on CLX (coverage note flagged in recent press), which is unlikely to trigger strong buying momentum; it keeps analyst sentiment around the stock cautious. Wells Fargo Hold
• Negative Sentiment: Zacks Research cut multiple near‑term EPS estimates (several quarters and FY2027 modestly lowered) and kept a “Hold” rating. The downward revisions signal weaker near‑term profit expectations and are the most direct driver of selling pressure today. (Source: Zacks research notes summarized across recent releases.)

Analysts Set New Price Targets

Several research firms recently weighed in on CLX. JPMorgan Chase & Co. upped their price target on shares of Clorox from $114.00 to $117.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 4th. Royal Bank Of Canada set a $132.00 price target on Clorox in a research note on Wednesday, February 4th. Citigroup raised their price objective on Clorox from $109.00 to $115.00 and gave the company a “neutral” rating in a report on Wednesday, February 4th. Morgan Stanley upped their target price on shares of Clorox from $125.00 to $136.00 and gave the stock an “equal weight” rating in a report on Thursday, February 5th. Finally, UBS Group increased their price objective on shares of Clorox from $115.00 to $121.00 and gave the company a “neutral” rating in a report on Wednesday, February 4th. One analyst has rated the stock with a Buy rating, eleven have given a Hold rating and four have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Reduce” and an average price target of $118.73.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.